DIAGNOSIS OF INTERNAL ORGAN INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS

Authors

  • Nabiyeva D.A., Mirxamidov M.V. Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

DOI:

https://doi.org/10.55640/

Keywords:

Rheumatoid arthritis; extraarticular manifestations; internal organ involvement; diagnosis; systemic inflammation; prognosis

Abstract

 Rheumatoid arthritis is a chronic systemic autoimmune disease characterized not only by progressive joint destruction but also by a wide spectrum of extraarticular manifestations involving multiple organs and systems. This review aims to analyze the patterns, classification, and diagnostic relevance of internal organ involvement in patients with rheumatoid arthritis. Published data indicate that extraarticular manifestations develop in approximately half of affected patients and may occur at any stage of the disease course. The clinical presentation is highly heterogeneous, ranging from mild cutaneous involvement to severe cardiovascular, pulmonary, neurological, renal, and hematological complications associated with increased morbidity and mortality. Classification based on severity and frequency provides a practical framework for clinical assessment, although no universally accepted system currently exists. The findings highlight that extraarticular involvement is more frequent in patients with high immunological activity, seropositivity, genetic susceptibility, and a history of smoking. Despite advances in disease-modifying and biological therapies, extraarticular manifestations remain a major diagnostic and therapeutic challenge. Early recognition, systematic evaluation, and multidisciplinary management are essential for improving prognosis and reducing disease-related complications in rheumatoid arthritis.

Downloads

Download data is not yet available.

References

1.Ganiyeva, N. A., Rizamukhamedova, M. Z., Nabiyeva, D. A., & Aripova, N. A. (2021). Clinic-Diagnostic Aspects of Modern Biomarkers of Early Atherosclerosis and Fibrotic activity of Systemic Scleroderma. Asian Journal of Medical Principles and Clinical Practice, 4(3), 1-13.

2.Aripova, N. А., Djurayeva, E. R., Abduazizova, N. X., Berdiyeva, D. U., Ganiyeva, N. A., & Ziyayeva, F. K. (2023). The role of pro-inflammatory cytokines in various types of systemic scleroderma. Seybold Rep. J, 18(06), 1469-1476.

3.Ганиева, Н. А., Джураева, Э. Р., & Арипова, Н. А. (2022). Комбинированная терапия синдрома рейно при системной склеродермии (Doctoral dissertation).

4.Bekenova, G. T., Axmedova, N. A., Ganiyeva, N. A., Asqarov, N. L., Tolipov, U. U., Alimova, N. Z., & Hasanova Sh, A. (2024). IMPORTANCE OF PULSE-THERAPY IN PERIPHERAL VASCULAR DAMAGE IN SYSTEMIC SCLERODERMA.

5.Арипова, Н. А. (2023). Изменения гемостаза у больных ревматоидным артритом в сочетании с ишемической болезнью сердца: дис.

6.Ганиева, Н. А. (2023). Значения интерлейкина-6 при системной склеродермии: дис.

7.Ганиева, Н. А. (2023). Оценка атеросклеротического поражения сонных артерий у больных системной cклеродермией: дис.

8.Набиева, Д. А., Ризамухамедова, М. З., & Ганиева, Н. А. (2015). Изучение эффективности плазмафереза у больных тофусной подагрой. Терапевтический вестник Узбекистана, (4), 93-96.

9.Мирзажонова, Г. С., Пулатова, Ш. Б., & Набиева, Д. А. (2023). Частота поражения сердца при анкилозирующем спондилите (Doctoral dissertation, Doctoral dissertation, Zamonaviy tibbiyotning dolzarb muammolari yosh olimlar xalqaro anjumani, Uzbekiston).

10.Набиева, Д. А., & Ризамухамедова, М. З. (2016). Взаимосвязи гиперурикемии и гиперлипидемии у мужчин с первичной подагрой. Juvenis scientia, (3), 27-28.

11.Aripov, A. N., Aripov, O. A., Akhunjanova, L. L., Nabiev, A. O., Nabieva, D. A., & Khamroev, T. T. (2022). Study the antifibrous efficacy of plant proanthocyanidin in rats with chronic heliotrine liver damage. Frontline Medical Sciences and Pharmaceutical Journal, 2(05), 16-25.

12.Ganiyeva, N. A., Rizamukhamedova, M. Z., Nabiyeva, D. A., & Aripova, N. A. (2021). Clinic-Diagnostic Aspects of Modern Biomarkers of Early Atherosclerosis and Fibrotic activity of Systemic Scleroderma. Asian Journal of Medical Principles and Clinical Practice, 4(3), 1-13.

13.Abduazizova, N. X., Nabieva, D. A., Pulatova Sh, B., & Sultanov, J. A. (2023). Lipid profile in patients with rheumatoid arthritis on the background of basic treatment. Asian journal of pharmaceutical and biological research, 12(2).

14.RIZAMUKHAMEDOVA, M., Nabiyeva, D., Dzhurayeva, E., Berdieva, D., Mukhammadieva, S., & ABDUAZIZOVA, N. (2020). Granulomatosis with Polyangiitis: Diagnostic Difficulties and Treatment. International Journal of Pharmaceutical Research (09752366), 12(2).

15.Nabiyeva, D. A. (2017). Dyslipidaemia and Cytokine Profile in patients wioth Gout: the role of IL-6, IL-18 and hyperurecemia in the development of metabolic disorders. Journal of Advances in Medicine and Medical research, (23.12), 1-10.

Downloads

Published

2025-12-25

How to Cite

DIAGNOSIS OF INTERNAL ORGAN INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS. (2025). Journal of Multidisciplinary Sciences and Innovations, 4(11), 2933-2940. https://doi.org/10.55640/

Similar Articles

1-10 of 854

You may also start an advanced similarity search for this article.